<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

M&A Front Cover

Section Partner:

CMS Cameron Mckenna -2

In Focus: M&A and Deal Making

LSX C-Suite Challenges in Life Sciences Survey 2018

In this extract from the LSX C-Suite Challenges in Life Sciences Survey 2018, we focus on senior executive respondents’ perceptions of M&As and other deal-making activities. This includes their future partnering goals, the roadblocks they come up against when seeking and establishing deals, as well as their views on what makes for a successful partnership and a sought-after partner. The LSX C-Suite Challenges in Life Sciences Survey 2018 has been designed to benchmark and give voice to the hurdles faced by C-level executives through key stages in the product and company development process.

Download the white paper to:
  • Discover what kind of deals and collaborations respondents intend to undertake over the year ahead.
  • Learn about the attributes senior life sciences executives look for in potential partners.
  • Read about the commonly-encountered obstacles to developing effective partnerships.
  • Better understand how to navigate M&A transactions through insight from Gary Green, Partner at CMS.
  • Find out about the latest deal trends from Dr Jill Ogden, Principal at Medius Associates.

The M&A and Deal Making report section and white paper are kindly supported by law firm CMS.

Enter your details here to receive the report

Formerly Known as Blog Resize

LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.